ADVANCED ENZYME TECHNOLOGIES
Back to Balance Sheet
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Total Non-Current Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Non-Current Assets | ₹731 Cr | ₹711 Cr | ₹688 Cr | ₹656 Cr | ₹633 Cr |
What is the latest Total Non-Current Assets ratio of ADVANCED ENZYME TECHNOLOGIES ?
Year | Total Non-Current Assets |
---|---|
Mar2025 | ₹731 Cr |
Mar2024 | ₹711 Cr |
Mar2023 | ₹688 Cr |
Mar2022 | ₹656 Cr |
Mar2021 | ₹633 Cr |
How is Total Non-Current Assets of ADVANCED ENZYME TECHNOLOGIES Trending?
Years | Total Non-Current Assets | % Change | |
---|---|---|---|
Mar2025 | ₹731 Cr | 2.79 | |
Mar2024 | ₹711 Cr | 3.35 | |
Mar2023 | ₹688 Cr | 4.98 | |
Mar2022 | ₹656 Cr | 3.55 | |
Mar2021 | ₹633 Cr | - |
Compare Total Non-Current Assets of peers of ADVANCED ENZYME TECHNOLOGIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ADVANCED ENZYME TECHNOLOGIES | ₹3,733.0 Cr | 1.9% | 2.7% | -14% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹405,872.0 Cr | -2.1% | 1.7% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,609.0 Cr | -1.5% | 1.5% | 46.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,277.0 Cr | 2.5% | 11.2% | 15.3% | Stock Analytics | |
CIPLA | ₹119,184.0 Cr | -1% | -1.7% | -1.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,116.0 Cr | -0.1% | -5% | -5.6% | Stock Analytics |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ADVANCED ENZYME TECHNOLOGIES | 1.9% |
2.7% |
-14% |
SENSEX | -0.1% |
1% |
1.8% |
You may also like the below Video Courses